Newsroom

Sorted by: Latest

-

SAFT Stock Alert: Halper Sadeh LLC is Investigating Whether Safety Insurance Group Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Safety Insurance Group Inc. (NASDAQ: SAFT) to an affiliate of Mapfre S.A. for $105.00 per share in cash.Halper Sadeh encourages Safety Insurance shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Safety Insurance a...
-

The Gorman-Rupp Company Announces CFO Succession Plan

MANSFIELD, Ohio--(BUSINESS WIRE)--The Gorman-Rupp Company (NYSE: GRC) announces that James C. Kerr, Executive Vice President and Chief Financial Officer, will be succeeded as Chief Financial Officer by current Vice President of Finance, Ronald F. Stoops, effective October 1, 2026. Mr. Kerr will assist with the transition and will continue to serve as a senior advisor to the Company until his retirement at a later date.Mr. Kerr joined Gorman-Rupp in 2016 and has served as Chief Financial Officer...
-

Gorman-Rupp Company Declares Cash Dividend

MANSFIELD, Ohio--(BUSINESS WIRE)--The Board of Directors of The Gorman-Rupp Company (NYSE: GRC) has declared a quarterly cash dividend of $0.19 per share on the common stock of the Company, payable September 10, 2026, to shareholders of record August 14, 2026. This will mark the 306th consecutive quarterly dividend paid by The Gorman-Rupp Company.About The Gorman-Rupp CompanyFounded in 1933, The Gorman-Rupp Company is a leading designer, manufacturer and international marketer of pumps and pump...
-

Central Pacific Financial Reports Second Quarter 2026 Earnings of $20.8 Million

HONOLULU--(BUSINESS WIRE)--Central Pacific Financial Corp. (NYSE: CPF) (the "Company"), parent company of Central Pacific Bank (the "Bank" or "CPB"), today reported net income of $20.8 million, or $0.80 diluted earnings per share ("EPS"), for the second quarter of 2026. This compares to net income of $20.7 million, or EPS of $0.78, in the prior quarter and $18.3 million, or EPS of $0.67, in the same period last year. “We delivered another strong quarter of performance, backed by our team’s dedi...
-

Gorman-Rupp Reports Second Quarter 2026 Financial Results

MANSFIELD, Ohio--(BUSINESS WIRE)--The Gorman-Rupp Company (NYSE: GRC) reports financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights Record net sales of $186.1 million increased 3.9%, or $7.1 million, compared to the second quarter of 2025 Record net income of $19.4 million, or $0.74 per share, compared to net income of $15.8 million, or $0.60 per share, for the second quarter of 2025 Adjusted EBITDA1 was $38.2 million and 20.5% of sales, an increase of $2....
-

NIQ Expands GenAI Capabilities Across gfknewron, Turning Trusted Intelligence into Decisions Faster

CHICAGO--(BUSINESS WIRE)--NIQ (NYSE: NIQ), a leader in consumer intelligence, today announced the expansion of AI-powered Smart Insights across its gfknewron® platform. By bringing together markets and categories into a single view, gfknewron enables businesses to transform complex market, consumer and supply chain data into clear, actionable intelligence quickly. The latest enhancements help users identify trends, opportunities and performance drivers more quickly, reducing the time required t...
-

CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending the marketing authorization of Trodelvy® (sacituzumab govitecan-hziy) in combination with Keytruda® (pembrolizumab), for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 23.07.2026 GRDU.LN IE000J80JTL1 42,700,002.00 USD 2,660,625,925.90 62.310  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 23.07.2026 LANDXEN.LN IE000C75IMX8 15,878.00 USD 317,470.45 19.994  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 23.07.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 751,815.29 22.089  ...